Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 15, 2025 07:45 ET | Source: Upstream Bio

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

Translational Data Presented at EACCI Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
June 05, 2025 07:00 ET | Source: Upstream Bio

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at EACCI 2025
June 04, 2025 07:00 ET | Source: Upstream Bio

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Upstream Bio to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
May 20, 2025 07:00 ET | Source: Upstream Bio

Upstream Bio Appoints Stacy Price as Chief Technology Officer

Upstream Bio Appoints Stacy Price as Chief Technology Officer
May 06, 2025 07:00 ET | Source: Upstream Bio

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
February 25, 2025 08:00 ET | Source: Upstream Bio

Upstream Bio to Present at Upcoming March Investor Conferences

Upstream Bio to Present at Upcoming March Investor Conferences
January 06, 2025 08:00 ET | Source: Upstream Bio

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024 08:00 ET | Source: Upstream Bio

Upstream Bio Appoints Allison Ambrose as General Counsel

Upstream appoints Allison Ambrose as General Counsel
November 21, 2024 08:00 ET | Source: Upstream Bio

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

Upstream Bio CEO to participate in fireside chat at Piper Sandler
September 09, 2024 08:00 ET | Source: Upstream Bio, Inc.

Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress

Upstream gives oral presentation of clinical data for verekitug in patients with severe asthma at European Respiratory Society congress

Next Page keyboard_arrow_right